Picture Name

HUAREN MEDICAL TECHNOLOGY

NEWS

05

2022-08

Negotiation of cooperation// Xiao Chun, Chairman of HYBRID PHARMACEUTICAL TECHNOLOGY (CHENGDU) CO.


On the morning of August 3, Xiao Chun, the chairman of HYPERTECH Medical Technology (Chengdu) Co., Ltd. visited Guangxi Huaren Medical Technology Group for research, accompanied by the leaders of the group. Accompanied by Group Vice President Zeng Yong and others, Chairman Xiao Chun visited the joint experimental center of Huaren Medical Science and Technology Group, and had a preliminary understanding of the research results and cases of our company in the fields of medical research and pharmaceutical research.

View More

05

2022-08

30 years of experimental mice breeding in space still being explored, what's the difficulty?


At 14:22 on 24 July, the Ask the Sky Experiment Module of the Chinese space station was launched from the Wenchang Cosmodrome in Hainan, and at about 3 a.m. on 25 July, the Ask the Sky Experiment Module caught up with the Sky and the Core Module after 13 hours of in-orbit flight to achieve a merger.

View More

29

2022-07

Good Voice and Good Story of Free Trade: Mainstream Media from Central and Autonomous Regions Visit Our Company


On the occasion of the third anniversary of the establishment of Guangxi Pilot Free Trade Zone, in order to comprehensively and three-dimensionally show the progress and effectiveness of the construction of China (Guangxi) Pilot Free Trade Zone, enhance the "free trade dividend" atmosphere of public opinion, and promote the realization of the high level of openness of Guangxi Pilot Free Trade Zone, high-quality development, the Office of the Pilot Free Trade Zone Construction Command organized and carried out the "free trade good voice and good story" publicity activities from July 18th to 28th.

View More

29

2022-07

Leaders of Nanning Liangqing District and their entourage visited our company for investigation.


In the afternoon of July 28th, Lu Guangping, Secretary of Nanning Liangqing District CPC Committee, Secretary of CPC Guangxi Liangqing Economic Development Zone Working Committee (concurrently), first-class researcher of Nanning Liangqing District, Wei Jin, Standing Committee of Nanning Liangqing District CPC Committee, Deputy Secretary of Nanning Liangqing District People's Government, Deputy Mayor of Nanning Liangqing District, brought with them the Investment Promotion Bureau, Development and Reform Bureau, Bureau of Economy and Information Technology, Bureau of Residential Development Bureau, Bureau of Finance, Bureau of Science and Technology, Land Reserve Sub-center, Party Committee Office, Party Committee Propaganda Department and other leaders visited Guangxi Huaren Medical Science and Technology Group and Guangxi Academy of Sciences Institute of Medicine and Health, and visited and researched our company's development, technological innovation and industrial layout, accompanied by a number of leaders of the group.

View More

23

2022-07

A Hundred Years of Life, Blossoming in the Sun 丨Huaren Group Starts from the Heart, Healthy Food Line Ready to Go


Health is the eternal theme of mankind, and the recommended food intake is an important part of a healthy diet. The dietary guidelines of most countries in the world recommend the intake of fresh and varied vegetables and fruits, moderate intake of animal foods such as fish, poultry, eggs and meat, limiting the intake of fat, salt, sugar and alcohol, and drinking sufficient water.

View More

08

2022-07

A new strategy for personalised cancer immunotherapy - dendritic cell nanovaccines


Dendritic cells (DCs) are specialist antigen-presenting cells that initiate an immune response against cancer cells, a process that involves DCs acquiring tumour antigens, such as mutated neoantigens or aberrantly expressed proteins, and presenting them to cytotoxic T lymphocytes (CTLs). In a clinical application called a DC vaccine, DC precursors are isolated from cancer patients, antigenically loaded and then infused back into the patient, a form of cell therapy that has shown promising clinical efficacy in cancer patients.

View More
< 1...131415...23 >